Estrogen Patch Shortage 2026: What to Do & Alternatives

If your pharmacy has turned you away, you're far from alone. In a survey presented at The Menopause Society's meeting in October, Midi Health reported that nearly half of its patients had struggled to get patches and 34% found their pharmacy out of stock; 10% of those affected had stopped hormone therapy altogether. That's company data, not a national survey, but it matches what doctors and pharmacists describe.

Mostly because far more women want them. Estradiol patch prescriptions rose from about 594,000 in June 2024 to 1.6 million in May 2026, according to HealthVerity data reported by CBS News, and patches now make up 44% of all estrogen prescriptions. The surge followed the FDA's November 2025 decision to remove the boxed warning from menopause hormone therapy labels, NBC News reported; our guide to the black box warning change explains what that decision did and didn't mean.

Patches are also hard to make more of quickly. They need specialized equipment, and manufacturers can't simply switch a pill line over, CNBC explained in June, when experts estimated it could take at least a year for supply to catch up.

Nobody has given a firm date. In a September 3 update, the FDA said it was working with all six patch manufacturers to raise supply and that patches remain available, even if not always at your usual pharmacy. Pressure is building for more: eight House members asked the FDA in August to add patches to its official shortage list, and three senators wrote in October asking what it would take for the FDA to declare a shortage, citing ASHP's count of nearly 20 patch formulations with supply problems. They asked for answers by November 16, 2026.

There is one new option on the shelf. In October the FDA approved the first generic of Climara Pro, a once-weekly patch that combines estradiol with a progestin, for women who still have a uterus.

Some are. Reuters reported on October 28 that the crunch is spreading as women look for alternatives: several estradiol injections are on ASHP's shortage list, and some vaginal estrogen creams are on backorder or allocation. Gels, sprays and pills have generally been easier to get, but availability varies by pharmacy and region, so it's worth calling ahead.

Start with the simplest swaps and work outward. Your prescriber makes the call, but these are the options to ask about:

• A different brand or strength of patch. The FDA suggests asking your pharmacist to look for another FDA-approved estradiol patch, AARP reports. A different manufacturer, or a twice-weekly instead of a weekly patch, may be in stock when yours isn't.
• Estradiol gel or spray. These go on the skin like a patch, so they're the closest switch in how the estrogen enters your body.
• Estradiol pills. Widely available and inexpensive, but swallowed estrogen behaves differently: it carries a higher clot risk than estrogen through the skin. Our comparison of the estrogen patch vs the pill covers who that matters for.
• A combined patch, if you have a uterus, such as the new generic Climara Pro.
• Compounded estradiol. Some providers offer compounded gels or creams, usually paid out of pocket. These aren't FDA-approved products, so ask what you're getting and why.

If you're between forms and struggling with symptoms, ask about non-hormonal treatments too.

Often, yes, mainly because a menopause specialist can switch your prescription quickly instead of leaving you to call round pharmacies. Midi says its clinicians can move patients to a weekly patch or a daily gel covered by insurance, or to compounded options paid out of pocket. Online providers can also send a new prescription to whichever pharmacy has stock. Our guide to getting HRT online walks through how it works, and online HRT costs breaks down what you'll pay.

If you're looking for a provider, our three highest-ranked are below. Whichever you choose, tell them which patch and strength you're on now, and that you're having trouble filling it.

Generally yes, with your prescriber setting the new dose. Doses don't convert neatly between a patch, a gel, a spray and a pill, so don't try to work it out yourself from a chart online. A few things your prescriber will want to check:

• Your clot risk. If you've had a blood clot, have migraine with aura, or have other clot risk factors, moving from the skin to a pill needs a proper review.
• Your progesterone. If you have a uterus, keep taking your progesterone whatever happens to your estrogen; it protects the lining of the womb. The dose may need adjusting after a switch. See our progesterone guide.
• How you feel in the first weeks. A new form can feel different. Note any change in hot flashes, sleep, bleeding or mood and report it.

And try not to stop abruptly. Symptoms often come back quickly, which is reason enough to get a bridging prescription sorted before you run out.

Not without asking. Some women are moved to two lower-strength patches when their usual strength is out of stock, but that's a prescription decision, not a home fix. Cutting patches is a different matter: many aren't designed to be cut, and the dose you get can become unpredictable. Don't stretch a patch beyond its wear time to make a box last longer either. If you're running low, call your prescriber now rather than the day you run out. You can also report supply problems to the FDA at drugshortages@fda.hhs.gov, as AARP notes.

Estradiol patches are genuinely hard to get in 2026 because demand jumped after the label change and production is slow to catch up. You have good options: another brand or strength, a gel or spray, a pill if your risk profile allows, or a combined patch. Let your prescriber make the switch, keep taking progesterone if you have a uterus, and don't cut, double up or stop on your own. We'll update this page as the FDA responds; last checked November 6, 2026. For the wider picture, read what changed for menopause hormone therapy in 2026 and is HRT safe?. This is general information, not medical advice.